Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2019 | 10-2018 | 10-2017 | 10-2016 | 10-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31 | 70 | 101 | 112 | 270 |
| Receivables | 4 | 116 | 91 | 121 | 85 |
| Inventories | 0 | 31 | 96 | 68 | 69 |
| TOTAL | $40 | $231 | $288 | $300 | $424 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 105 | 152 | 194 |
| TOTAL | $0 | $0 | $105 | $152 | $194 |
| Total Assets | $40 | $232 | $394 | $452 | $618 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 52 | 82 | 62 | 44 | 109 |
| Accrued Expenses | 10 | 23 | 195 | 9 | N/A |
| TOTAL | $82 | $109 | $273 | $68 | $111 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $82 | $109 | $273 | $68 | $111 |
| Shareholders' Equity | |||||
| Common Shares | 4,192 | 4,192 | 4,192 | 0 | 0 |
| Retained earnings | -4,290 | -4,125 | -4,259 | -4,000 | -3,871 |
| Other shareholders' equity | 56 | 56 | 188 | 192 | 186 |
| TOTAL | $-42 | $123 | $121 | $384 | $507 |
| Total Liabilities And Equity | $40 | $232 | $394 | $452 | $618 |